QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Thyroid Cancer|Colon Cancer|Ovarian Cancer|Breast Cancer|Lung Cancer|Pancreatic Cancer
Interventions: BIOLOGICAL: ETBX-011|BIOLOGICAL: ALT-803
Sponsor: NantCell, Inc.